Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Blog PRIME Medicine Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First in Class Twincretin Diabetes Therapy Springer Nature Link Meet the Americans who make their own weight loss drugs Reuters Cagrilintide Research Peptide Information Peptpedia Switching to Tirzepatide 5 mg From Glucagon Like Peptide 1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment Endocrine Practice